1. Trends in the rates of health-care providers’ recommendation for HPV vaccine from 2012 to 2018: a multi-round cross-sectional analysis of the health information national trends survey
- Author
-
Joël Fokom Domgue, Robert Yu, and Sanjay Shete
- Subjects
Adult ,Health Knowledge, Attitudes, Practice ,medicine.medical_specialty ,Vaccination Coverage ,Cross-sectional study ,030231 tropical medicine ,Immunology ,03 medical and health sciences ,0302 clinical medicine ,Surveys and Questionnaires ,Health care ,Humans ,Immunology and Allergy ,Medicine ,Papillomavirus Vaccines ,030212 general & internal medicine ,Pharmacology ,business.industry ,Papillomavirus Infections ,Vaccination ,Hpv vaccination ,Cancer ,medicine.disease ,Health Information National Trends Survey ,Cross-Sectional Studies ,Family medicine ,business ,Research Paper - Abstract
The 2012 report of the President’s Cancer Panel highlighted the overriding contribution of missed clinical opportunities to suboptimal HPV vaccination coverage. Since then, it remains unknown whether the rates of provider recommendations for the HPV vaccine in the US population have increased. We conducted an analysis of four rounds of the Health Information National Trends Survey (HINTS), a household survey of civilian US residents aged 18 y or older. A total of 1,415 (2012), 1,476 (2014), 1,208 (2017), and 1,344 (2018) respondents to the HINTS survey who were either HPV vaccine-eligible or living with HPV vaccine-eligible individuals were included. Overall, the rates of providers’ recommendations remained stagnated from 2012 to 2018 in all categories of the study population, except for non-Hispanic Blacks (NHBs), where this prevalence increased during the study period (AAPC = 16.4%, p
- Published
- 2021